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ABSTARCT 
Ganoderma lucidum is generally called “Lingzhi or Reishi”, and also be a Traditional Chinese medicine utilized in over 2000 y for their better 
therapeutic activity like antitumor, antiallergenic, antiviral, hepatoprotective, antioxidant, hypotensive, immunomodulator, hypoglycemic, anti-
inflammatory, antithrombotic, antibacterial and many other health benefits. Ganoderma lucidum is one of the oldest herbal remedy found and grow 
in wide variety parts on deciduous trees (dead/dying tree) specifically in oak, pyrus, maple, elm, willow, sweetgum, magnolia, locust, acer, betula, 
castanea, coryolus, fagus, populus, plums and other plants species. It also be contains 400 major bioactive chemical constituents include 
polysaccharides, triterpenoids, polysaccharide-peptide complex, β-glucans, lectins, natural germanium (Ge), adenosine, phenols, steroids, amino 
acids, lignin, vitamins, nucleotides or nucleosides possesses specific curative properties and formed a wide variety of viable products from 
Ganoderma fruiting bodies, mycelia, spores i.e. coffee, powder, dietary enhancements, tea, spore items, drinks, syrups, toothpastes, cleansers or 
creams. Many in vitro or in vivo analyses with regards Ganoderma lucidum evidenced their antitumor activity but some conducted clinical studies 
are questionable and remains undefined for their antitumor effect. Though, we reviewed and summarized in this article about treatment and 
various pharmacological mechanism against tumor with respect to extract (polysaccharide and triterpenoid) of Ganoderma lucidum.  
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INTRODUCTION 
Medicinal mushrooms are fungal organisms that contain fruit-body 
of fungus and considered as traditional medicinal agents as health 
foods, nutritional supplements and nutraceuticals. The utilization of 
remedial fungal mushrooms for promotion of health, permanency 
and for illness since long in East Asian countries where Traditional 
Chinese Medicine has used as herbal preparations for a large 
number of years but the use is slightly increasing in Western world 
since the last few years [1-4]. However, Asia is also the historical site 
of mushroom cultivation is reported in China in 12th century. 
Nowadays, China is responsible for 70% of the world’s mushroom 
production [2]. 
In between the cultivation and traditional system of medicine, 
fruiting bodies of certain mushrooms types of Ganoderma are 
utilized as conventional medication in China or another Asian nation 
for across 2000 y which elevates health and endurance to brings 
down the threat of malignant growth, increases immune activity, in 
treatment of frailty or faintness, sleep disorder, diabetes and other 
health benefits or properties. A variety of trade items are developed 
from Ganoderma fruiting bodies, mycelia, spores include powder, 
dietary enhancements, tea, spore items, drinks, syrups, toothpastes, 
cleansers and creams, which marketed as valuable crude medication 
supplements and effective health food for health benefits [5-7]. 
One of the oldest medicinal mushrooms, Ganoderma lucidum 
considered as wood-decaying fungus or phytopathogenic fungus 
that forming by white rot of wide variety of trees, which has longest 
history of use. Ganoderma lucidum are most desired remedial 
mushrooms utilized widespread medication in china or japan over 
2000 y meant for wide series of diseases prevention [8, 9, 3, 6]. 
Ganoderma lucidum are derived from words “Gano (Greek) or 
lucidus (Latin) means shiny or brilliant” and “derma (Greek) means 
skin” refers to smooth appearance of the surface of mushroom. The 
Chinese name of Ganoderma lucidum refers as–“Lingzhi” and “Reishi” 
or in Japan called “Mannentake” [7]. As per Chinese traditional 
culture, the word of “Lingzhi” (Ganoderma lucidum) considered as 
the combination of spiritual potency, the essence of immortality or 
stared “herb of spiritual potency”, sign of happiness, good wealth, 
symbolizing success, divine power and longevity [7, 4]. The 
medicinal property or value of Ganoderma lucidum has been 
documented in gone back almost 2000 y of Chinese literature to 
Shen Nong Materia Medica (102–200AD). In excess of 120 
Ganoderma types become described on earth among that 98 species 
occurred originate in China. But, just 2 forms of Ganoderma such as 
Ganoderma lucidum (Leyss. ex Fr.) Karst or Ganoderma sinense Zhao, 
Xu et Zhang remain recognized into Chinese Pharmacopoeia (2010) 
named Lingzhi [4].  
 
 
Fig. 1: Lingzhi mushroom (Ganoderma lucidum) [58] 
 
Ganoderma species are more often disseminated in humid or 
temperate areas globally in a few kinds with dark, red, purple, light, 
yellow and white or around 250 species of this mushroom are 
identified mainly in tropical area of India. Ordinarily used medicinal 
Ganoderma species i.e. Ganoderma Lucidum, Ganoderma tsugae 
Murrill, Ganoderma capense Junhua or Ronglan and Ganoderma 
applanatum (Pres.) Pat. have their own characteristic’s biological 
properties and physiological effect. Each type of Ganoderma species 
considered in unmistakable laccate or non-laccate, sessile to stipitate 
basidiomata, binary-walled basidiospores or interwall columns [10, 8].  
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Ganoderma lucidum is beneficial and popular remedy which exhibit a 
wide range effect of anti-cancer/anti-tumor activity via improving 
TNF-a, IFN-g and IL-2 (initiated at Purdue University in the United 
States) or anti-aging via raising α-DNA polymerase and anti-HIV by 
suppression of virus proliferation. Shell broken Ganoderma spore 
extracts are also effective in combination with chemotherapy or 
radiation therapy for the treatment of the patient with late-stage 
cancer, which allows undergoing surgery, chemotherapy or 
radiation therapy. The other significant property of active 
constituent in Ganoderma lucidum has display a beneficial effect in 
treating a several diseases include persistent hepatitis, joint pain, 
hypertension, hyperlipidemia insomnia, neoplasia, asthma, diabetes, 
anti-inflammatory, antimutagenic, anticarcinogenic, antitumor, 
nephroprotective, cardioprotective or in other diseases conditions 
[11, 8].  
Global production 
Ganoderma lucidum is normally developed in China, Taiwan, Japan, 
Korea, Malaysia or North America and also common in tropical and 
warm temperate regions of India. The worldwide creation of 
Ganoderma around 4900-5000 tons in year of 2002, out of that 3800 
tons remained to turn out in China and annually 4300 tonnes 
production were cultivated artificially in over 10 countries. However, 
approx. 2-billion-dollar estimated world trade of this mushroom or in 
India, about Rs 120 crores were projected annual market for 
Ganoderma-based nutraceuticals (Unspecified 2002). While USA is 
considered as a biggest market for medicinal mushrooms or their 
items. In this manner, the natural product assemblage of Ganoderma 
lucidum is retailed in market Rs 600-700/Kg [9].  
The overall market estimation of remedial mushrooms estimated 
about US $6.0 billion in 1999 that increased $18.0 billion in 2014. The 
growth of these market product was expanded in over last 25 y that 
are more greatly in North America. In year of 1990, only a limited 
nutritional supplement companies offering mushroom products but in 
year of 2015 every company has offering one or more mushroom 
preparations in their product line [2]. Thus, mushrooms signify a chief 
or to a great extent, an accessible wellspring of powerful drug product 
about 10,000 known species of mushrooms, out of which 2000 are 
harmless for individuals' wellbeing and around 300 have significant 
therapeutic properties [8].  
Biological source 
Ganoderma lucidum (M. A. Curtis: Fr.) P. Karst comes under class 
Basidiomycetes, has a place with the family Polyporaceae or 
Ganodermataceae and order of Aphyllophorales. The 
Ganodermataceae family derived from “Gano” means shiny or bright 
and “derma” means skin, a varied group of saprophytic fungi sustain 
on wood and having a bright or shiny surface covering the fruiting 
body. Its fruiting bodies recognized as “Lingzhi” by Chinese, “Reishi 
or Mannentake” by Japanese, “Chaga” by Russian, “Lingchich” in 
American or “Youngzhi” in Korean that means “Herb of Spiritual 
Potency”, representing achievement, prosperity, divine strength, and 
longevity [12, 4, 6, 7, 9]. Ganoderma lucidum similarly be utilized as a 
health-promoting folk remedy and turned into a “king of herbs” for 










United States: Reishi mushroom, Ganoderma. 
China: Lingzhi, Lingzhi Cao, Ling Chih, Hong Ling Zhi, Chi Zhi. 
Japan: Reishi, Mannentake, Rokkaku Reishi. 
Korea: Young ji. 
Vietnam: Ling chi. 
Russian: Chaga. 
American: Lingchich. 
Korean: Youngzhi [13, 14]. 
Geographical source and habitat 
Ganoderma lucidum (fruiting body) are generally found and grows in 
densely wooded mountains of high humidity or both tropical and 
temperate geographical areas and far countries in Asia, China, Japan, 
Africa Taiwan, Korea, North and South America and Europe [15, 6]. 
It is mainly grown in wide variety parts of Himalayas on deciduous 
trees (dead/dying tree), specifically in oak, pyrus, maple, quercus, 
elm, willow, sweet gum, magnolia, locust, acer, alnus, betula, tilia, 
castanea, coryolus, fagus, fraxinus, populus, plums and less acquired 
in coniferous trees i.e. larix, picea, pinus. It is mostly growing on 
plum trees and furthermore found on bases usually close to the soil 
exterior or rarely rising from repressed roots [16, 6]. 
Ganoderma species consume an inclusive multitude variety in excess 
of 44 species from 34 genera of plants actuality recognized by means 
of probable hosts. Plant-pathogenic or wood-crumbling Ganoderma 
varieties influenced to affect extreme ailments include stem decay, 
butt decay and root decay in financially significant plants or recurrent 
harvests in tropical nations [17]. Whereas dietary mushrooms offered 
an extensive assortment of therapeutic properties which is compelling 
against convinced serious illnesses. However, around 1.5 million 
classes of fungi have been identified globally out of which almost 
82,000 are defined and around 5,000 are palatable and 2,000 safe 
known species belong to macrofungi [18].  
Chemistry 
Ganoderma comprises 400 different bioactive compounds, primarily 
situated in glossy fruiting body, mycelium or spores. Ganoderma 
mycelia contain high molecular weight bioactive ingredient 
polysaccharides, which found to be heteropolymers with monomer 
units of xylose, mannose and galactose and also be carry auxiliary 
metabolites included as triterpenoids, alkaloids, proteins, coumarin, 
flavonoid, phenols, lignocellulose debasing enzymes or nucleosides. 
Whereas Ganoderma products Reishi teas are rich source of water-
soluble polysaccharides [4, 6]. Several triterpenoids of Ganoderma 
spores are isolated from ethyl acetate fraction, which includes as 
Ganoderic acid, Methyl ganoderate, Ganodermic Acid, estero sterol 
peroxide and have been identified with common Movalonic acid 
pathway. The fruiting body of Ganoderma has been studied for his 
chemical constituents and focus on spores have their biological 
activity against several diseases and health and inflammatory 
conditions [6]. 
Historical background 
The Chinese name of Reishi mushroom (lingzhi) formerly described 
a “shaman crying for rain”, that represents magical or heavenly 
assets be situated by lingzhi and generally considered as “Mushroom 
of Immortality”, “Ten-thousand-year Mushroom”, “Mushroom of 
Spiritual Potency”, or “Soul Plant”. Ganoderma lucidum (Reishi) 
mushroom was recorded between 120 prevalent stimulants (Shang 
pin) in many popular Chinese Materia Medicas (Shen Nung Ben Cao 
Jing). However, Red Reishi located beneficial to chest binding 
treatment, tonify the heart, sustain the middle, hone the mind or 
develop the memory [14].  
Ganoderma lucidum (Curtis) P. Karst or Lingzhi/Reishi, a woody 
polypore (Basidiomycota) assume a crucial part of therapeutic 
mushroom in Chinese or Japanese traditions in any event of 2000 y. 
However, the term “Lingzhi” in China measured a powerful herbal 
medicine and signify a spiritual strength, improves wellness and 
longevity. The impression of “Lingzhi”, mushroom with mystical 
powers was primary looked in Qin Dynasty (221–207 BCE). 
“Lingzhi” is significant folk Chinese medicine but declarations about 
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concept of Lingzhi were initiated in India with a Vedic plant called 
“Soma” (Soma-haoma). More than 200 Ganoderma species were 
known yet just two species i.e. Ganoderma lucidum (W. Curtis: Fr.) P. 
Karst or G. sinense Zhao, Xu et Zhang, remain formally documented 
named “Lingzhi” in Chinese Pharmacopoeia was inscribed in Ming 
Dynasty (A. D. 1590) recorded with similar or beneficial 
pharmacological properties [19, 17].  
The fungus of Ganoderma was first seemed in Chinese fiction in Han 
Dynasty (206 B. C.–220 A. D.) and was authenticated in first book 
which exclusively dedicated to portrayals of herbs or their 
restorative qualities was “Shen Nong Ben Cao Jing” recorded in Han 
Dynasty (206 BCE–220 CE) or Eastern Han dynasty of China (25-220 
AD). This book likewise represents “Classic of the Materia Medica” 
(502-536 A D) or “Shen-nong Herbal Classics” or permitted “Ben Cao 
Gang Mu” by Li Shin-Zhen which called an original Chinese 
pharmacopoeia (1590 AD, Ming dynasty). It defines botanic, 
zoological, or mineral substances, was collected in 2nd
Bioactive chemical constituents  
century 
beneath alias of Shen-nong (“Divine Farmer”) and persistently 
efficient and reached with valuable impacts of a few mushrooms 
concerning Ganoderma lucidum therapeutic mushroom. An Emperor 
Wu has developed the growth inward Majestic Palace compartment 
by herb of immorality recognized basically by means of Chih plant or 
Chih fungus. While, “Lingzhi” is cited in 2000 y old poem written by 
Han Dynasty chronicler, Pan Ku and utilizing the expression “ling 
chih”. Though, the term ling Chih, afterwards transformed to Reishi 
by Japanese and association among unique Chih fungus or 
Ganoderma lucidum evidently procure starting folklores of a prior 
secretive Chih fungus and Chih herb of immortality according India 
documentation. In early 800 y ago, “Lingzhi” is characterized in 
canvases, wood carvings, carvings of jade and deer’s prongs, 
furniture, cover plans, balustrades, jewels, ladies' hair brushes, 
fragrances, crafted works or several artistic artworks by Yuan 
Dynasty (A. D.1280–1368). Consequently, Ganoderma lucidum has 
assigned with therapeutic properties (State Pharmacopoeia of 
People’s Republic of China, 2000) or medicinal remedy in Far East 
countries (North America and Europe) for old time in therapy of 
neurasthenia, sleeping disorder, anorexia, hepatopathy, nephritis, 
faintness, bronchitis, asthma, gastric ulcers, persistent hepatitis, 
hypercholesterolemia, mushroom poisoning antidote, coronary 
illness, hypertension, carcinoma or bronchial cough in mature age. 
As per Traditional Chinese Medicine (TCM), and Japanese herbalists 
stated various kinds of Ganoderma lucidum have different tastes and 
distinctive biological activity and also be classified six unique sorts 
of Ganoderma lucidum (Reishi mushroom) on the basis of color i.e. 
green, black, white, red, yellow, and purple [7, 16, 17]. 
Ganoderma lucidum contains 400 bioactive constituent which play 
vital role in various therapeutic activity. Major bioactive 
constituents are polysaccharides, triterpenoids, polysaccharide-
peptide complex, β-glucans, lectins, natural germanium (Ge), 
adenosine, phenols, steroids, amino acids, lignin, nutrients, 
nucleotides or nucleosides with its particular therapeutic properties 
i.e. immune-modulators, antioxidants, chemo preventive or 
tumoricidal [18].  
 
 




Triterpenes are subclass of terpenes which comprise 6 isoprene 
units. These isoprene’s units by and large direct ties or overlay up or 
a ring-like structure. Around 140 types of triterpenes and 
triterpenoids estimated in Ganoderma lucidum having molecular 
weight in between 400 to 600 kDa or complex substance structure 
or profoundly oxidized. The center of triterpenes structure depends 
upon lanostane i.e. metabolite of lanosterol are biosynthesized by 
squalene cyclization.  
Triterpenoids also favoring with beta-glucans in immune system 
activation and also be responsible for bitter taste of Reishi, that a 
rapid method of defining the quality of Reishi product. Ganoderic 
acid is subtypes of triterpenes or major bioactive compound in 
Ganoderma lucidum involve four cyclic and two linear isoprenes and 
the carboxyl group, answerable for some natural impacts such as 
anti-inflammatory, against tumorigenic, anti-HIV and hypolipidemic 
activity. Over 150 highly oxygenated and pharmacologically active 
ganoderic acid (A, AM1, B, C1, C2, D, DM, F, G, H, K, Me, Mk, S, T, TR, 
Y), triterpenoids, ergosterol, Lanostane derivatives were extracted 
from other fungi of Ganoderma and Ganoderma lucidum genus 
(fruiting bodies, spores, and mycelia) and other include Ganoderols 
(A, B), Ganosporeric acid A (another triterpenoid, secluded from 
ether-solvent division of spores), Ganoderic acid α, Ganoderiol F, 
Ganodermatriol, Ganoderal A, Methyl ganoderate D, Ganoderate G or 
Lucidenic acid A,O, Lucidenic lactone and Cerevisterol having their 
significant biological activity.  
Some of triterpenes were extracted more than 20 y i.e. ganoderic acids U, 
V, W, X or Y established cytotoxicity against hepatoma cells in vitro and 
Ganoderic acids A or C inhibited farnesyl protein transferase (enzyme in 
initiation of Ras oncoprotein involved in cell changes). The newly 
extracted ganoderic acids γ, δ, ε, ζ, η or θ didn’t interfered in any activity 
against cancer cells. However, Ganoderic acid T is record significant 
malignant growth impacts by inhibiting MMP-9 expression (Matrix 
Metalloproteinase-9) in both In vitro or In vivo examines. Triterpenes 
with low molecular weight can mark cellular progressions include 
apoptosis, cell cycle regulation or angiogenesis by absolute connection 
among sub-atomic levels. While, Ganoderic acid D shown directly effect 
by binding with 14-3-3ζ protein which improve to apoptosis in HeLa cell. 
Whereas, Ganoderiol F (GA-F) considered a tetracyclic triterpene 
demonstrated cytotoxicity in vitro in opposition to Lewis lung carcinoma 
(LLC), Meth-A, Sarcoma-180, and T-47D cell lines [20-26, 1, 2, 6, 7, 16].  
Carbohydrates 
Polysaccharides 
About 200 different polysaccharides include glucose, xylose, 
mannose, galactose and fructose (β-D-glucans, α-D-glucans, α-D-
mannans or polysaccharide-protein complexes) were isolated from 
Ganoderma lucidum (Reishi) fruitbodies, spores, mycelia having 
molecular weights around 4 × 105 to 1 × 106 Daltons. The basic 
outline of Ganoderma lucidum polysaccharide contain α-or β-(1→3)-, 
(1→4), (1→6)-glucans linked main chain with single β-(1→3)-
connected D-glucopyranosyl by parts of mono-, di-or 
oligosaccharide side chains replacing at C-6 glucosyl deposits and 
other hetero-saccharides formed to glucose, mannose, Uronic acid 
galactose, xylose, fucose, rhamnose, arabinose remained identified 
in 10–50% in dry Ganoderma lucidum.  
Although, cereal endosperm beta-glucans are rectilinear polysaccharides 
made out of cellotriosyl-and cellotetraosyl-units connected (1→3)-beta 
and smaller level of cello oligosaccharides of higher-level polymerization 
also linked (1→3) -beta-existing polysaccharides. Ganoderma lucidum 
polysaccharides (GL-PSs) exhibited in wide-range biological activities 
with various diverging adaptations or dissolvability influenced in various 
immune reactions with variable immune influences and other anti-
inflammatory, hypoglycemic, antiulcer, antitumorigenic and 
immunostimulant effects. However, β-D-glucans involving (1-3)-, (1-4)-
or (1-6)-β-D linkages showed stronger anti-tumor potency, improving 
absorption, host immune response and persuading cytotoxic pathways 
contrasted with different polysaccharides in Ganoderma lucidum [21, 23-
26, 1, 2, 6, 7, 16].  
Phenolic compounds 
Phenolic compounds exhibit antioxidative and antiradical activity 
revealed to scavenge free radicals, contribute hydrogen, chelate 
metal ions, interrupted radical chain responses or extinguish singlet 
oxygen in vitro or in vivo. It contains backbone of glucose residues 
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connected via β-(1→3)-glycosidic bond which oftenly linked through 
side-chain. The scavenge free radical’s mechanism are influenced in 
certain regulating pathological conditions include ageing, cancer, 
Alzheimer’s disease, heart diseases, neurodegenerative disorders, 
atherosclerosis, cataracts and inflammation and also exhibited in 
antimicrobial properties against Escherichia coli, Pseudomonas 
aeruginosa, Staphylococcus aureus or Klebsiella pneumoniae [1].  
Sterols 
Sterols assume an urgent part in keeping proper structure or 
province of all eukaryotic cells. Over 20 forms of sterols were 
estimated in Ganoderma lucidum or their skeletons separated within 
ergosterols (in fungi) or cholesterols. Almost 6 sterols components 
were found in fruiting body of Ganoderma lucidum exhibit antiviral 
activity against Epstein bar virus and several pharmacological 
effects include anti-HIV-1, anti-ageing properties or protective 
cerebral cortical neurons from hypoxia or re-oxygenation injury. 
However, a component of Ganodosterone (a Ganoderma derived 
sterol involve in inhibiting cholesterol synthesis) has been extract as 
a steroid which influenced antihepatotoxic [24, 1].  
Proteins 
Mycelium of Ganoderma lucidum contains Ling Zhi-8 (LZ-8) protein, a 
polypeptide having molecular mass 12 kDa and made out of 110 
amino acid deposits with an acetylated amino end. LZ-8 be similar to 
biological activities and heavy chain of immunoglobulins then lectins 
with mitogenic activity and immunomodulatory effect to mouse spleen 
cells, human peripheral lymphocytes, agglutination of sheep red blood 
cells, effective suppressor of bovine serum albumin-initiated 
hypersensitivity in CFW mice in vitro. LZ-8 proteins also possessing 
strong antioxidant properties by inhibiting the oxidative reaction or 
altering the physical site of transition metals making insoluble metal 
complexes. While, Ganodermin isolated from Ganoderma lucidum 
display antifungal assets in contrast to Botrytis cinerea, Fusarium 
oxysporum and Physalospora piricola [16, 22, 24, 1].  
Nitrogenous compounds 
Nucleotides and nucleosides 
Ganoderma lucidum (Reishi) comprises nucleosides i.e. adenosine 
cysteine, guanosine, inosine, thymidine, uridine just as nucleotides 
are adenine, guanine, hypoxanthine, thymine or uracil [16, 22, 24].  
Enzymes 
The major protein enzymes are extracted from Ganoderma lucidum 
included as β-N-Acetyl hexosaminidase, α-1, 2-mannosidase, endo-β-
1,3-glucanase, β-1,3-glucanase or glutamic protease. 
Amino acids 
Almost 18 types of amino acids are identified in Ganoderma lucidum 
or extremely important amino acid are Leucine having durable 
hypoglycemic or antioxidant actions [24].  
Other constituents 
Ganoderma lucidum (Reishi) comprises oleic acid, cyclo-octa sulfur, 
ergosterol peroxide (5,8-epidioxy-ergosta-6,22E-dien-3-ol), 
cerebrosides (4/8E)-N-D-2-hydroxystearoyl-1-0-β-D-glucapyran-ocyl-
9-methyl-4-8-sphingadienine or (4/8E)-N-D-2-hydroxypamitoyl-1-D-
β-D-glucopyranosyl-9 methyl-4-8-sphingadienine, flavonoids, tannins, 
coumarins and anthocyanin. Moreover, some vitamins include 
vitamins B1, B2, B6, β-carotene, C, D, E were identified. Whereas, 
spores of Ganoderma lucidum comprise choline, tetracosanoic acid, 
betaine, stearic acid, palmitic acid, ergosta-7,22-dien-3-ol, non-
adecanoic acid, behenic acid, tetracosane, hentriacontane, ergosterol 
and β-sitosterol and a pyrophosphosphatidic acid lipid. While, 
Alkaloids (stimulate central nervous system, antimicrobial, 
sympathomimetic, vasodilator, antihypertensive, antipyretic and anti-
malarial), vitamins, essential minerals, flavors and fatty acids (inhibit 
histamine) were identified [16, 18, 1]. 
Inorganic ions  
Ganoderma lucidum contains major inorganic ions are Magnesium, 
Calcium, Zinc, Iron, Copper, and Geranium whereas, Ash of 
Ganoderma lucidum contains minerals of potassium, sodium, 
phosphorus, chromium, arsenic, silicon, aluminum, cobalt, 
molybdenum, nickel, and lead [18, 24, 7]. 
Nutritional values 
Nutritional value and composition may affect by several factors 
include changes between strains, development substrate, 
technique for cultivation, phase of collecting, definite segment of 
fruiting bodies for identification. The formation of Ganoderma 
lucidum concentrate (% of dry weight) contained Folin-positive 
material (68.9%), glucose (11.1%), protein (7.3%) or metals 
(10.2%) K, Mg, Ca, Ge (489μg/g). However, starch content 
fermented control reduced expressively (**P≤0.001) from 64.5 to 
25.3% as well as content of reducing sugar enhanced expressively 
(**P≤0.001) 4.2 to 20.6%. Consequently, solid state fermentation 
(SSF) likewise expressively (**
Cultivation and collection 
P≤0.01) expanded 11.0 to 16.5% in 
protein matter [18]. 
Ganoderma lucidum (Reishi) are generally originate in living and 
dead wood of deciduous trees cultivates in subtropical or temperate 
climate areas in China and Asian countries i.e. Japan or Korea, USA, 
Europe or South America. In Far East countries its mostly grows in 
dead trees of Japanese plum (Prunus salicina). While, in Europe it 
found in dissimilar species of deciduous trees in summer and 
Autumn seasons. Whereas, In Poland it is found in the 
Świętokrzyskie mountains. Moreover, it mostly cultivated dead or 
dying trees include oak, alders, plum trees, maple, elm, willow, sweet 
gum, magnolia, locust or fewer located on coniferous tree i.e. larix, 
spruce, ptea and pinus [27, 22, 18].  
During ancient time, Ganoderma lucidum were extracted primarily 
from forest. But in the past, it is cultivated in small amounts only in 
wild because of very expensive. Traditional cultivation and axenic 
cultivation measured the most common in several yields, is faster or 
more practical. Although, in last 10 y it is generllay cultivated by 
artificial methods on media of wood meal, rice grain, wood wedges 
in China, Japan and United States were increased for better 
production. Artificial cultivation of Ganoderma was tried in 1937 
and first efficacious cultivation of 1035 Ganoderma was achieved in 
1969 by using spore separation cultivation method in Chinese 
Institute of Microbiology or Chinese Academy of Sciences (Beijing). 
The way toward making Ganoderma lucidum fruiting bodies is like 
more cultivated comestible mushrooms involves firstly preparing 
the fruiting culture, stock culture, mother spawn or planting spawn. 
Whereas, secondly preparing development substrates for mushroom 
cultivation.  
Meanwhile, late 1980 a new method is remodeled the usage of 
short logs (15 cm or less) for their cultivation, today this 
technique is best for Ganoderma characteristic-log cultivators in 
China, Japan and Korea, which takes which takes a while to create 
the fruiting body, mycelia-based or culture broth-based items to 
guarantee quality control and constant creation in the year. 
Several environmental factors are important of cultivation of 
Ganoderma lucidum genus i.e. oxygen level and calcium ion 
concentration and different geographical regions. Recently, there 
are several other methods assumed for viable production of 
Ganoderma lucidum such as basswood cultivation, sawdust 
cultivation, substituted cultivation, short wood portion, tree 
stump, sawdust pack, and bottle methods [28, 16]. Agricultural 
wastes have been attained using substrates include grain, wood 
log, tea waste, cotton seed husk, sunflower seed hull, corn cobs, 
olive oil press cakes. However, sawdust and wood chips added 
with rice, wheat bran, finger millet or ragi as substrate (9:1 ratio) 
be applicable for Ganoderma lucidum cultivation for higher 
productivity, extensive or significant market value. Currently, 
Ganoderma lucidum isn't just species developed for a marketable 
reason in global in numerous types of crude medication, dried 
preparations, phytomedicines and teas yet additionally 
Ganoderma applanatum, Ganoderma capense, Ganoderma sinense, 
Ganoderma tsugae or Ganoderma neo-japonicum occur developed 
in accessible homesteads [29-33, 7, 14, 17, 19]. 
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Fruiting Body-Annual, smaller with cap and stalk, intermediate, an 
infrequent antlered structure. 
Cap-Rounded to crescent, flat, rounded, fan or kidney formed, 2-20 
(35) cm wide, 30 to 250 mm in diameter, 4-8 cm thick, superior 
smooth surface, irregularly knobby or concentric waves, corky, 
rough, with or without stained emergence, shiny, red, cherry-red, 
reddish-brown or reddish-black in color, dark red to reddish brown 
or reddish black in middle, ochre/yellowish to sideline, flesh 
yellowish brown to dark brown, undeveloped fruitbodies are 
yellow-brown, yellow-red or by mature darker color, stipe is glossy, 
sporadically wound or 50-120x10-20 mm in size, hymenophore is 
trimitic, elastic, corky, fine, whitish, beige or brown color.  
Pores-1 or 2 spore film creating tubes with 2-20 mm long, pores 
minute, thick 4-7/μm, whitish while crisp, maturing or wounding 
earthy colored, surface yellowish cream, pore 6 for each mm, 
unpredictable, tube 3–5 mm long, unstratified, whitish brown.  
Stalk-3-14 cm long, 0.5-4 cm thick, turned, amplified at base, similar 
shading or appearance as top surface. 
Antler form-Rare antlered type of Ganoderma lucidum is profoundly 
valued remedially in China and Japan that grows normally or 
developed in situations with slight light and significant levels of 
carbon dioxide. 
Aroma-moldy and fungus alike.  
Taste-Depend upon strain and triterpenes may be strongly 
unpleasant.  
Bitter fracture-Tough, sinewy, relentless, crushing into strips 
disclose dissimilar film of fruiting body. 
Powder-Light to dark brown, lenient, flexible or gristly, pieces of 
Plectenchyma of cap, dark brown sections of tubes, basidiospores. 
Distribution-Mostly saprophytic nonetheless might be parasitic on 
the bottom, roots or stumps of hardwoods, infrequently on conifers, 
diverse in distribution [34, 14, 22]. 
Microscopic Identification  
Mushroom naturally breaks into little strips slightly than framing a 
characteristic powder. Whereas, powder is made up 3 types hyphae 
i.e. generative, binding or skeletal with rare basidia or basidiospores 
(spores). Reproductive hyphae consist of shrill-walled, colorless, 
clamps or concise branching. While, binding hyphae (horizontally or 
vertically) also consist colorless, thicker walls or immensely 
extended with slim tightening closes. Moreover, skeletal or basic 
hyphae primarily fruiting body consist of thick-walled, yellowish-
earthy colored or somewhat extended, cap are more obscure in 
shading or palisade appearance or adjusted closures.  
Cross segment of Ganoderma species formed external portion of cap 
is coriaceous with distended yellow-shaded hyphae (closely packed 
with very thin plectenchyma) as well as inward portion of cap 
displays a grid of gray colored hyphae about 2-7 μm in width. 
Vertical tubes at inferior segment of cap are dark brown in color 
with width 200 μm and internal face is enclosed with light hymenial 
stroke with dark brown basidiospores. Basidia are ellipsoidal or 
spathulate, inconsistent, meager-walled or frequent. Spores are 
ovoid or curved among sprinkled surface with 8 μm long and spore 
edges are multiplied along more obscure inward film over external 
hyaline layer forming sparkling appearance. Starch and calcium 
oxalate are missing [14].  
Medicinal uses 
Ganoderma lucidum has been effective for treatment of several disease 
with most significant Pharmacological or Physiological results such as 
immunomodulatory, immunodeficiency, anti-cancer, anti-oxidant 
(radical scavenging properties), antiallergic, anti-inflammatory, 
antiparasitic properties, anti-viral (AIDS, HIV infections), anti-
bacterial, anti-atherosclerosis, anti-androgenic, anti-diabetic 
(hypoglycemic), anti-fungal, anti-aging, stroke, anti-fibrotic, 
antiherpetic property, prevention of obesity, hypolipidemic, kidney 
tonic, heart diseases (hypertension), stimulation of probiotics, 
stomach ulcers, effects on nervous system (sleep-promoting, stress, 
mental fatigue, migraine), liver diseases (liver detoxification, 
hepatitis), arthritis, reduction of lower urinary tract symptoms, 
nephritis, bronchitis, asthma [35-40, 28-31, 18-22, 26, 33]. 
Therapeutic effect and antitumor activity of Ganoderma lucidum 
 
 
Fig. 4: Anti-tumor activities of Ganoderma lucidum 
 
Effect on colorectal cancer 
Colorectal cancer is major health problem in few nations or one of 
the upper three malignant growths analyzed in United States. A 
study in 2008 and 2009, the extracts of Ganoderma lucidum 
displayed to obstruct colon cancer by inhibiting cell expansion or 
persuaded programmed cell death in human colon cancer cells by in 
vivo and in vitro models. However, a report verified that Ganoderic 
acid T extract by Ganoderma lucidum inhibits development of HCT-
116 and HT-29 colon cancer cell line in rodents via affecting cell 
cycle (G0/G1 stage) or induced autophagy through increasing 
autophagic vacuoles growth or also be raised Beclin-1 or LC-3 
expression. Additionally, an aqueous concentrate of Sporoderm 
(spores) Ganoderma lucidum polysaccharides (GLPS) inhibited 
feasibility of HCT-116 colorectal malignant growth cells and 
functions of RTKs i.e. PS-F2 in dose dependent manner as well as 
assuming a significant part in adjustment of MAPKs, JNK, p38, ERK 
or NF-κB that is influenced TNF-α in cancer signaling stimulation. In 
Lewis Lung Carcinoma (LLC) model Ganoderma lucidum decreased 
tumor expansion, expression of matrix metalloproteinase (MMP-2 
or-9) mRNA or reduced progression in metastatic disease. In HT-29 
xenograph model, Ganoderma lucidum triterpene include 
Ganodermanontriol (GNDT) inhibits development of HCT-116 or 
HT-29 (expanded the degrees of E-cadherin or β-catenin proteins) 
colon cancer cells by affecting cell cycle to decrease cyclin D1 
expression (Cdk-4 and PCNA expression) in the tumor [41, 19].  
Moreover, a study reported Ganoderma lucidum polysaccharide 
(GLP) decreased cell feasibility on HCT-116 cells. The western blot 
analysis of Ganoderma lucidum polysaccharide inclined the Bax/Bcl-
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2, caspase-3 or-9, poly (ADP-ribose) polymerase (PARP) appearance 
and informed inducing GLP apoptosis in human colorectal cancer 
cells influenced in DNA division, reducing mitochondrial membrane 
potential, raising in S stage population, mitogen-activated protein 
kinase (MAK) pathways stimulation or inhibition in c-Jun N-terminal 
kinase (JNK) by SP600125 in dose dependent manner [4].  
Effect on prostate cancer 
Anti-tumor activity by Ganoderma lucidum on PC-3 prostate cancer 
cells in molecular component STAT-3 molecule or Jak-1 are 
concurrently defined the fundamental apoptotic properties to kept 
or censored transcriptional oncogenic STAT-3 target genes that 
inhibit growth of PC-3 cells in dose-dependently and confines 
growth and raises apoptosis by depending status of STAT-3 or Jak-
1pathway in the cells. Moreover, Ganoderma lucidum particularly 
effective and disabled STAT-3 (translocation) signaling pathway or 
proliferative marker articulation, serious cytotoxicity, ROS deposit, 
offend increasing cyclin-D1, Bcl-2 articulation, dense Bax, caspase-9 
and 3 articulations or apoptosis in PC-3 cells by time dependent 
manner [42]. 
Additionally, a study revealed the ethanol or ethyl acetate 
concentrates of Coprinus comatus or Ganoderma lucidum prevent 
dihydrotestosterone instigated LNCaP cell feasibility via. arrest G1 
phase in LNCaP or defeat degrees of discharged prostate precise 
antigen in dose-dependent manner. However, the C. comatus or 
Ganoderma lucidum combination also reduced androgen receptors 
protein level in LNCaP and glucocorticoid receptors transcriptional 
movement in MDA-kb2 breast cancer cells in dose-dependent 
manner [4]. 
Effect on breast cancer 
Anti-cancer action of Ganoderma lucidum suppress breast cancer 
cells enlargement via preventing Akt/NF-Kappa B signaling. A 
current research study stated that gold nanoparticles (Au-NPs) 
produced from Ganoderma lucidum or conjugated with drug 
doxorubicin displayed strong anticancer or cytotoxic activity against 
MCF-7-doxbreast cancer cell line (97%) by Au-NPs at higher 
concentration was 400μM/ml that is beneficial for treatment of 
breast cancers. While, mRNA expression of ABCB1 gene and CDNA 
made from human breast cancer cell line (MCF-7) confirmed 
reduced expression [20].  
Additionally, an examination directed in mice involving 
exceptionally invasive human breast cancer cells are embedded 
among mice breast tissues or administered Ganoderma lucidum once 
daily, noticed terminate breast-to-lung metastasis by pro-invasive 
genes inhibition. Then, an investigation issued in Journal of Cancer 
Research in April 2015 described the combination of Ganoderma 
Lucidum with Lapatinib in HER2+inflammatory breast cancer cells 
produced strong effect in SUM190 or KPL-4 cell lines or decreased 
the cell feasibility. Moreover, a study published in PLoS (2012) or 
directed of utilizing Ginseng and Ganoderma lucidum after finding of 
breast cancer in 4,149 patient’s results 14.2 or 58.8% displayed a 
noteworthy impact on quality of life. Another examination displayed 
Ganoderma lucidum concentrate decreasing the tumor development 
by decreasing E-cadherin and eIF4GI expression in inflammatory 
breast cancers [27]. 
In a study, Ganoderma lucidum produced anti-tumor effects in 
human ovarian OVCAR-3 cancer cells via suppressing/restrains cell 
development or interruption of cell cycle development by 
suppressing cyclin D1. Though, chemo preventive actions produced 
by Ganoderma lucidum were established in initiation of antioxidant 
SOD, catalase, phase-II detoxification enzyme NAD(P)H: Quinone 
oxidoreductase 1 (NQO1) or glutathione S-transferase P1 (GSTP1) 
through Nrf2 intervened signaling pathway [43].  
Another study displayed the treatment of Ganoderma lucidum inhibit 
propagation of human ovarian cancer cells (HOCC) via decrease in 
VEGF appearance or rise in Cx43 expression in cancer cells. 
However, Ganoderma lucidum concentration was associated with 
level of immune-reactivity of Cx43 and VEGF (helping ovarian tumor 
genesis or growth) by cancer cells. Although, decreased expression 
of Cx43 in human ovarian cancer cells (HOCC) terminate impact of 
Ganoderma lucidum on cell multiplication or lacking change in 
reduction of VEGF articulation in dose dependent manner that 
lessened cell proliferation in HOCC [44, 4].  
Effect on hepatoma cancer  
A study described, Ganoderic acid A (GA-A) produced significant effect 
by suppression of proliferation and blocked phosphorylation/ 
activation of transcription factor STAT3, bringing about improved 
affectability of hepatoma cells to cisplatin. However, it should be 
demonstrated in 69-year old male patient with persistent hepatitis B 
infection created hepatoma cancer cells (HCC) was administered 
Ganoderma lucidum and Gan Fu Le (Chinese herbal medicine in 
treatment of hepatocarcinoma) after the analysis, results in following 
3 mo the liver mass as well as tumor size was intensely decreased and 
in first several 10 y observed significant decrease in HCC and no 
changes in raising degree of α-fetoprotein (AFP) in serum (a tumor 
factor for distinguishing patients with HCC) were detected.  
Alternative effect demonstrated in 72-year-old female patient with 
elevated level of AFP (alpha fetoprotein) and several malignant liver 
abrasions or single metastatic injury administered Ganoderma lucidum 
or Pian zhi Huang (utilized in hepatitis) repeatedly, after 12 mo 
diagnosis the lesion was reduced with decline AFP levels. But, in third 
instance of 78-year-old male patient with metastatic HCC and AFP 
level consistent increment after Ganoderma lucidum treatment till 
discontinuing doxorubicin treatment (chemotherapeutic agent) [26].  
Additionally, a study displayed inhibitory impacts of Ganoderma 
lucidum stagnant spores, developing spores, sporoderm-broken 
germinating spores (SBGS) or isolated lipids germinating spores on 
development of mouse hepatoma, sarcoma S-180 or reticulocyte 
sarcoma L-II cells results sporoderm-broken spores produced a lot 
of advanced bioactivities and effect on tumor size compared with 
whole spores. Consequently, Ganoderma lucidum lipids extract from 
developing spores or sporoderm-broken germinating spores 
repressed 80-90% of three tumors in dose dependent manner [4].  
Effect on bladder cancer  
A study demonstrated the ethanol concentrate of Ganoderma lucidum 
was estimated with cooperation of BCG in premalignant human 
uroepithelial cells (HUC-PC) model, resulted Ganoderma lucidum 
shows the direct cytotoxic effects whereas BCG exhibited delayed 
response by initiating the discharge of interleukin (IL)-6, IL-8 or 
monocyte chemotactic protein-1 (MCP-1). Moreover, the synergistic 
cytotoxic impacts detected after cancer cells remained incubated with 
the two medication and either be pretreated with Ganoderma lucidum 
(increased IL-6, IL-8, MCP-1). Consequently, Ganoderma lucidum or 
BCG be confirmed to attain total cytostatic effect in 24 h or impacts 
remained developed within 5 d. Yet, certain frequent proinflammatory 
cytokines are allied with high adverse reaction of BCG, marks the 
Ganoderma lucidum proposed to enhance with BCG immunotherapy in 
bladder malignancy meant for improved efficacy and diminishing the 
adverse reaction [45].  
Another study exhibited chemo-preventative impacts of Ganoderma 
lucidum via in vitro human urothelial cell (HUC) model with HUC-PC 
or MTC-11 cells. They demonstrate the ethanol or water 
concentrates of Ganoderma lucidum (fruiting bodies or spores) 
utilized observe the progression inhibition, actin polymerization 
activity, effect on actin remodeling on cell migration or adhesion. In 
outcome’s ethanol extracts of Ganoderma lucidum displayed 
powerful growth inhibition impact by cell cycle study to G2/M arrest 
compared with water extracts. While, these extracts of non-cytotoxic 
concentrations are 40–80 mg/ml persuaded actin polymerization 
that repressed carcinogen 4-aminobiphenyl produced passage in 
equally cell lines. However, enhanced actin polymerization is allied 
by amplified stress filaments or focal adhesion complex 
development but articulation of matrix metalloproteinase-2 or focal 
adhesion kinase remained unaffected that proposes to involved with 
different process of chemo preventive effect [46, 4].  
Effect on lung cancer 
Active constituent of Ganoderic acids found significant absolute cancer 
cell cytotoxicity on extensive assortment of cancer cell lines include 
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murine Lewis lung carcinoma (LLC), Meth-A or a large number of 
different angiogenesis and metastasis. While, the effect of Ganoderic acid 
T incites apoptosis of metastatic cellular breakdown in the lungs by 
inherent pathway associated with mitochondrial dysfunction produced 
more effective anti-cancer activity [47]. The in vitro analysis of triterpene 
aldehydes, lucialdehydes A-C isolated with Ganoderma lucidum fruiting 
bodies exhibited cytotoxicity against murine or human tumor cells. 
Whereas, blazein steroid extracted with Agaricus blazei stated to 
provoke cell demise or morphological variation suggestive of apoptotic 
chromatin reduction in human lung cancer cells [48]. 
In a study of plasma-incited lymphocytes inhibition in lung cancer 
patients are received Ganoderma lucidum polysaccharides (GLPS) 
produced significant effect by antagonizes immune inhibition 
toward enable tumor control in animal model or certain 
immunosuppressive mediators include PGE2, TGF-β, IL-10 or VEGF 
are delivered from cancer cells. Thus, treatment of Gl-PS is effective 
for suppress propagation, CD69 articulation, perforin or granzyme B 
formation via lymphocytes by Phytohemagglutinin (PHA) 
stimulation in lung cancer patient’s plasma [4].  
A study assessed inhibitory impact of Ganoderma lucidum 
triterpenes on cell multiplication or tumor development with IC50 
24.63μg/ml upon A549 cells produced significant effect by 
inhibition of tumor development in Lewis tumor-bearing mice with 
dose 30, 60, 120 mg/kg or marker of immune organs such as spleen 
or thymus remained strangely expanded via triterpenes treatment. 
Additionally, in vitro study estimated that L-fucose (Fuc)-enriched 
Reishi polysaccharide fraction (FMS) have been effective in 
inhibition of development of malignant growth cells by increment in 
antibody-mediated cytotoxicity or decrease in formation of tumor-
related inflammatory mediators mainly monocyte chemoattractant 
protein-1 (MCP-1). While, in vivo examines displayed remarkable 
rise in peritoneal B1 B-cell populace signifying FMS-mediated anti-
glycan IgM formation. Another, current study exhibited that plasma 
of patients with lung cancer obstruct propagation, CD69 appearance, 
perforin and granzyme B production in lymphocytes through 
polyhydroxyalkanoates (PHA). Although, an alternative study 
described Ganoderic acid Me (lanostane triterpene give to 
indoleamine 2,3-dioxygenase) of Ganoderma lucidum facilitated in 
production of a tolerogenic element in lung tumors via. Initiating T 
cell apoptosis influenced in repressing CD8+T cell activation or 
increasing Treg-mediated immunosuppression [49].  
Effect on gastric cancer 
A research study described effect of gastric adenocarcinoma cell line 
(AGS) by mushroom concentrate results improved development of 
autophagosomes and cell levels of LC3-II but decreased p62 level that 
confirming with influences cellular autophagy. Moreover, treating cells 
via mushroom concentrate in conjugation through lysosomal protease 
inhibitors displays cellular degrees of LC3-II or p62 were raised. So, 
conclusions acquired demonstrated AGS cells treated with Ganoderma 
lucidum methanolic concentrate affects autophagy initiation more 
relatively decrease over autophagic transition [50, 4]. 
Moreover, a study conducted in 2015 described six triterpenoids 
include ganolucidic acid E, lucidumol A, ganodermanontriol, 7-oxo-
ganoderic acid Z, 15-hydroxy-ganoderic acid S or ganoderic acid 
(GA) extracted in Ganoderma lucidum displayed inhibition growth of 
cell lines i.e. Caco-2, HepG2, HeLa cells via apoptosis via different 
concentration with IC50s 20.87–84.36 mmol [19].  
Another research study examines the polysaccharide effect (expansion 
or apoptosis) on cultured human gastric cancer SGC7901cells that 
display the growth of refined cells remained controlled through higher 
concentration polysaccharide treatment for longer period. The refined 
cells achieved distinctive apoptosis, equally morphological characters 
or DNA fragmentation later 10 mg/ml polysaccharide treatment 
intended for 48 h, resulted the 40% refined cells existing via. apoptosis 
yet the outflow of BCL-2 protein was down-regulated as well as 
concentration of BAX protein was up-regulated. Consequently, this 
study showed that polysaccharide actuate human gastric cancer cells 
apoptosis or detain cells growth that help to use for human gastric 
cancer active therapy [51]. 
  
 
Fig. 5: Anti-cancer or Immunomodulatory actions of Ganoderma lucidum polysaccharides (GLPS) [28] 
 
Other effects of Ganoderma lucidum 
Immunomodulation 
A number of different components from Ganoderma lucidum are 
used as immunomodulating agents proved to improvement of 
immunological effector, induction of cytokines, build up the 
expansion and T or B lymphocytes development, splenic 
mononuclear cells, NK cells or dendritic cells are demonstrated in 
vitro or in vivo animal reports [7].  
Consequently, in vitro or in vivo studies in mice showed that water 
concentrate of Ganoderma lucidum stimulates IL-2 (presence of 
hydrocortisone) production by splenocytes, T cells activators, or 
bringing cytokines production. In vitro water concentrate of 
Ganoderma lucidum in human peripheral blood mononuclear cell 
(PBMC) exhibit the induction via cytokines appearance i.e. TNF-a, IL-
10, IL-1b, IL-6 or L-2 as well as Ganoderma lucidum water-extracted 
polysaccharide element improved splenic NK cells cytotoxicity in 
tumor-bearing mice and activation of macrophages by cytokines 
liberation, NO or different mediators exhibited anti-tumor, anti-
microbial anti-inflammatory effect, antiproliferative, separated or 
apoptosis inducing to HL-60 or U937 leukemic cells. However, the 
antibody-neutralization studies revealed that IFN-g or TNF-a 
delivered by macrophages interfered synergistically obstruct 
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development of leukemic cells. additionally, the methanol extract of 
Ganoderma lucidum (Ganoderic acids C or D) inhibit histamine 
discharge from rat mast cells are actuated via composite 48/80 or 
concanavalin A results, ganoderic acids C or D showed strongly effect 
in inhibition of histamine liberate from rat mast cells through 
screening test. Moreover, triterpenoid compounds namely cyclo-octa 
sulfur produced positive effect in prevented histamine discharge in rat 
peritoneal mast cells by reacting membrane proteins near prevent Ca 
uptake producing a histamine activation obstruction [16].  
Antioxidant Activity 
Triterpenes or polysaccharide extract of Ganoderma lucidum 
exhibited antioxidative properties in mice splenocytes by means of 
expanding movement of antioxidant enzymes, reducing radiation-
induced oxidative DNA impairment and oxidative damage induced 
by ROS [1]. The antioxidant and chelating property of 
phytoconstituents of Ganoderma capably scavenged O2, OH radicals 
produced experimentally during in vitro studies. The effect of 
Ganoderma lucidum antioxidant property, scavenging, gathering 
capacities and absolute phenol component has been showed in a 
study by ethanol or water concentrate from Ganoderma lucidum 
exhibited maximum scavenging action in contrast to DPPH radicals 
with 50% inhibitory concentration by 0.055±0.001 mg/ml. An 
alternative study observed the endogenous mitochondrial DNA 
damaged via free radicals significant scavenging and related aspect 
to aging and also found effects of extract of vital antifatigue and 
rejuvenating activity [3].  
Additionally, many investigations have been completed to assessed 
antioxidant property with respect to several fragments of 
Ganoderma lucidum i.e. fruiting body and mycelia. Meanwhile, the 
methanolic or aqueous extract have shown great free radical 
scavenging activity of superoxide free radicals, hydroxyl radicals and 
inhibit the lipid peroxidation. Thus, a number of different models of 
antioxidant activity assay have been performed with the extracts of 
Ganoderma species include alcoholic, aqueous alcoholic, petroleum 
ether and chloroform exhibited maximum antioxidant activity in hot 
water followed by aqueous alcoholic extract. While, petroleum ether 
extract produced minimum effect in scavenging the free radicals in 
any of models of antioxidant assays include DPPH and ABTS radical, 
superoxide radical scavenging assay [6]. 
Antidiabetic activity 
Ganoderma lucidum exhibit the antidiabetic effect by interfering in 
multiple pathways including insulin-releasing activity via enabling 
of Ca2+inflow to pancreatic β cells and diminution in fasting serum 
glucose levels with reduced mRNA expression levels involved in 
gluconeogenesis and glycogenolysis. In a study of china examined 
hypoglycemic impact of Ganoderma lucidum polysaccharides by 
utilizing I. P infusion by single doses (25, 50 or 100 mg/kg) extract 
in fasted mice, resulted the polysaccharides decreased serum 
glucose levels at 3 to 6 h. afterwards administration of extract in 
dose dependent manner and also be increased circulating insulin 
levels or intensity of [Ca2+
Moreover, Ganoderma lucidum (Ganoderans B or D) isolated 
polysaccharide displayed probable hypoglycemic and hypolipidemic 
activities confirmed by preclinical studies in rat involving 
administration of Reishi (Ganoderma lucidum) protected against 
diabetic nephropathy or enhanced injury palliate in streptozotocin-
induced diabetic rats. However, clinical studies with 71 patients 
caused type II diabetes mellitus (DM) estimate the anti-diabetic 
efficacy and safety technique was carried out. Consequently, these 
studies reported Ganoderma lucidum (Ganopoly) was well tolerated, 
efficacious and safe for use comparable to oral hypoglycemic drugs 
or insulin [18, 1].  
] at 1 h after administration [52].  
Additionally, a study evaluated the effect of aqueous extract on 
blood glucose levels in alloxan induced diabetic rats (Wistar) via 
intraperitoneally administered of 3 doses extract of (250, 500 or 
1000 mg/Kg) Ganoderma lucidum. Antidiabetic impact showed at 
doses 500 or 1000 mg/Kg of concentrate by decrease (**P≤0.05) 
blood glucose levels of alloxan induced diabetic rats (Wistar) by 4, 8 
or 24 h. time period but not fundamentally vary blood glucose levels 
with 250 mg/Kg doses. therefore, dosage 1000 mg/Kg of 
concentrate demonstrated together critical (**
Another study confirmed the petroleum ether extract (PEE) or 
methanol extract (ME) of Ganoderma lucidum mushroom decreased 
plasma glucose levels in alloxan or steroid initiated fasting diabetic 
rats in dose dependent manner with maximum reduction 55.57% 
detected by PEE at dose 800 mg/kg or 36.01% ME at dose 800 
mg/kg in alloxan prompted or 51.41% PEE or in steroid-induced 
diabetic rats by 32.02% ME. Moreover, in treatment with metformin 
(150 mg/kg) shows decrease of fasting blood glucose levels via 
60.02 or 51.12% in alloxan or steroid induced diabetic rats. 
Whereas, equally PEE (800 mg/kg, 
P≤0.05) hypoglycemic 
or anti-hyperglycemic impacts [53]. 
**P≤0.001) or ME (800 mg/kg, 
**P≤0.01) increased plasma insulin levels and decreased HbA1c 
(**P≤0.01 or *
Anti-inflammatory activity 
P≤0.05) in alloxan or steroid induced diabetic rats [54]. 
The extract Ganoderma lucidum (Reishi) presented an effective anti-
inflammatory property in human keratinocytes reported in 
preclinical studies of animals inhibited the inflammatory damage in 
carrageenan induced inflammation or produced a beneficial effect 
against arthritis [1]. An alternative Indian study established that the 
extract of Ganoderma lucidum (β-1,3-or β-1,6-D-glucans) produced 
significant effect by decrease inflammation in dose or time-
dependent manner. They found that dose of Ganoderma lucidum 
(100 mg/kg B. W) exhibited anti-inflammatory activities equivalent 
toward diclofenac dose (10 mg/kg B. W) by 50% decrease in 
inflammation in mouse models. While, several bioactive constituents 
involve in Ganoderma lucidum i.e. Polysaccharide or water insoluble 
β-1,3-D revealed the inhibition of LPS-animated nitric oxide 
formation via macrophages or reduces pro-inflammatory cytokines 
by mRNA gene expressions such as iNOS, IL-1, or TNF-α in dosage 
dependently by patent incentive IL-10 and pointedly increased in 
anti-inflammatory cytokine IL-10 via treatment of Selenium 
nanoparticles. Additionally, anti-inflammatory impact of Ganoderma 
lucidum reports displayed adjuvant impacts include enhancing the 
maturation of dendritic cell (DC) by upregulating CD40, CD80, CD54 
and CD86 markers on peripheral blood monocytes [55, 41]. 
Another report suggests around 20% of the cancers are measured 
by the effect of inflammation due to the chronic overexpression of 
inflammatory cytokines include IL-6, VEGF or TNF-α leads to 
promote carcinogenesis. However, administration of triterpene 
concentrates of Ganoderma lucidum fundamentally suppress 
inflammatory cytokine discharge by macrophage cells that reducing 
degree of inflammation [20].  
Antimicrobial activity 
The antimicrobial property of Ganoderma lucidum and their 
bioactive constituent remain largely undefined or not clearly 
understood but, given with broad spectrum antimicrobial agents, the 
extracts might be inhibited Gram-positive or Gram-negative 
bacteria. An examination reported that fruit body aqueous or 
organic solvent (hexane, dichloromethane, ethyl acetate) of 
Ganoderma lucidum concentrate be situated similarly prohibition in 
opposition to all assessed strains include Pseudomonas aeruginosa, 
Proteus vulgaris or Enterococcus faecalis excepting Listeria 
monocytogenes and minor inhibitory impact reported in contrast to 
Salmonella typhimurium, Klebsiella pneumoniae, Streptococcus 
mutans or minimum impact against Bacillus subtilis but, organic 
solvent extract displayed low solvation ability for antimicrobial 
agents separation. Additionally, several studies revealed the 
methanolic extract exhibited complex inhibitory property compared 
to S. aureus or B. cereus as well as Enterobacter aerogenes, 
Escherichia coli or Pseudomonas aeruginosa comparable toward 
ampicillin and streptomycin antibiotics with minimal inhibitory 
concentrations about 0.0125–0.75 mg/ml or bactericidal 
concentration are 0.035–1.5 mg/ml [21].  
Another study displayed the Ganoderma lucidum extract (Reishi) 
also inhibit development of Helicobacter pylori (bacteria cause 
gastric ulcers or gastric cancer). Whereas, isolated compound from 
Ganoderma lucidum showing antifungal action by interfered mycelial 
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development of Botrytis cinerea, Trichoderma viride, Fusarium 
oxysporum or Physalospora piricola than that of antifungal agents 
such as bifonazole and ketoconazole [22].  
Antiaging activity 
Ganoderma lucidum isolated polysaccharide compound produced 
significant effect by inhibit ROS production in fibroblasts and UVB 
induced MMP-1 protein expression, improved procollagen 
expression as well as stimulate C-telopeptides of type I collagen 
protein by inhibiting ERK pathways. Therefore, various research 
studies demonstrated in long-term on scavenging free radical and 
ROS accelerates aging and many age-related illnesses [22].  
In a study reported various extractions include ethanol extract, 
aqueous extract, mycelia extract or water-soluble extract from 
Ganoderma lucidum mycelia, Ganodermasides A, B, C, D or medicinal 
constituents-polysaccharides I, II, III, IV, Ganoderma peptide, 
Ganoderma polysaccharide peptide, triterpenes or Ganoderic acid 
C1 might utilize in life expectancy extension or correlated activities. 
Whereas, studies revealed that Ganoderma lucidum as a preparation 
utilized many thousands of years and exposed its impact on life 
expectancy expansion and being confirmed to anti-aging remain also 
rare associated with Ganoderma lucidum extractions and 
constituent’s actuality revealed [56]. 
Antiviral activity 
Antiviral activity of Ganoderma displayed by the constituents of 
Ganomycin I (farnesyl hydroquinone) and Ganomycin B isolated 
from Vietnamese G. colossum produced strong effect by inhibited 
HIV‑1 protease through IC50 value 7.5 or 1.0l μg/ml. however, 
constituent of Ganomycin B competitively equally blocked enzyme 
active site to docking beside HIV‑1 protease crystal structure [48]. 
Additionally, the various research demonstrated impacts of 
Ganoderma lucidum on HIV with strong inhibitory properties. While, 
a study analyzed more than thirteen compounds extracted from 
Ganoderma lucidum exhibited anti-HIV-1 property via inhibiting 
HIV-1 proteases including triterpenoids (major compound has 
strong anti-HIV effects) and Ganoderic acid (GA-A). Whereas, 
Ganoderma lucidum comprises laccases that might inhibit HIV-1 
reverse transcriptase [25].  
 
 
Fig. 6: Health benefits of Ganoderma lucidum (Lingzhi) [7] 
 
Effect on cardiovascular function  
Ganoderma lucidum (Reishi) exhibited a positive effect on 
cardiovascular system by reducing in blood cholesterol levels, 
triglyceride levels or normalize blood pressure. A clinical study 
described the patients with starting phase of hypertension showing 
maintained blood pressure were detected following 2 mo by 
Ganoderma lucidum extract treatment. Moreover, the examinations 
displayed the Ganoderma lucidum extract (polysaccharide and peptide 
complexes) decreased blood lipid level or prohibited growth of 
atherosclerosis in rats and furthermore indicated a preventive activity 
with respect endothelial cells of blood vessels in peoples [22]. 
Another clinical study carried out in Japan with 53 hypertensive 
individualized subjects involving 240 mg of 6 tablets of Ganoderma 
extract were administered daily for 6 mo treatment to the active 
group results, showed that extract forming tablet of Ganoderma 
lucidum produced strong effect on lowering of blood pressure and 
hypertension and also showed no side effects relating to Ganoderma 
treatment [6]. 
Hepatoprotective activity 
Hepatoprotective property of Ganoderma lucidum (Polysaccharides 
and Triterpenoids) against liver damage actuated via harmful 
synthetic compounds (CCl4), Bacillus Calmette-Guerin (BCG) in 
addition to lipopolysaccharide (LPS) given orally and 
intraperitoneally to estimate markers i.e. aspartate, alanine 
transaminases (AST or ALT) or lactate dehydrogenase (LDH) have 
been demonstrated by various in vitro studies on animals. A present 
randomized placebo-controlled clinical study presented 12 w 
Ganoderma lucidum polysaccharides treatment showed significant 
decrease hepatitis B e-antigen (HBeAg) or HBV DNA via 25% 
(13/52) patients per Hepatitis B virus infection. However, 90 
persistent hepatitis B patients, hepatitis B viral (HBV) DNA positive 
or aminotransferase remained increase in multicenter probable 
randomized Phase I or II analyses [16]. 
A study reported that Ganoderic acid’s hot water extract offered 
mice orally for 30 min. prior ethanol administration identified a 
strong inhibitory impact on β-glucuronidase or malondialdehyde 
(MDA) development in mice liver or renal homogenate and also be 
reported that pretreatment by Ganoderma lucidum kept up ordinary 
estimations of AST, ALT, SOD or GSH. Whereas, a study suggest the 
MDA effect reported after concentrate was offered mice orally with 
dose 60, 120 or 180 mg/kg daily for 2 w before D-galactosamine 
therapy to prompted hepatic injury.  
Additionally, the alcohol and CCl4 toxicity may influenced in 
increasing oxidative stress or free-radical-related liver injury hence, 
hepatoprotective activity of hot water Ganoderma lucidum extract 
exhibited substantial radical-scavenging property compared to 
equally superoxide or hydroxyl radicals. Furthermore, the 
Ganoderma lucidum methanolic concentrate administered orally for 
rats with dose 500 mg/kg daily at 30 d prior hepatic injury induced 
via benzo(a)pyrene exhibited preventive in rise serum AST, ALT, 
alkaline phosphatase (ALP) or also GSH, SOD, GpX, CAT, glutathione 
S-transferase (GST). Another study observed hepatoprotective 
activity against liver injury persuaded through CCl4 in mice with 
Ganoderic acid (10 or 30 mg/kg daily) administered in I. V infusion 
for 7 d. Moreover, the oral administered Ganoderma lucidum mycelia 
exhibit valuable impacts via lower serum AST or ALT actions at 96 h. 
post liver injury and no change in decrease transaminase activities 
at 24 h in control animal studies. However, a study reported an 
extracellular peptidoglycan formed through mycelium fermentation 
remained given to rats orally for 4 d earlier CCl4 intoxication that 
displayed rising serum ALT levels remained expressively reduced in 
70% at 24 h postinjury equated to untreated or intoxicated rats and 
also decreased AST levels in 27% [7].  
Clinical studies 
Human studies 
Clinical studies are carried out in cancer patients for testing of 
Ganoderma Lucidum conducted some in China with observed 
significant positive results. A clinical study through Ganoderma 
lucidum polysaccharide concentrate detected to expansion in plasma 
levels immune markers, IL-2, IL-6, interferon γ (IFN-γ) or in NK cell 
activities and other study exhibit more positive responses with 
using Ganoderma lucidum in mixture with chemotherapy/ 
radiotherapy results an increase certain level of immunological 
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markers are CD3, CD4, CD8 were observed. however, a compiling 
database for randomized controlled trials (RCTs) made by Cochrane 
Collaboration in 2012 suggested that hardly 5 RCTs of 257 
investigations could fulfill standards for presence all groups of 
patients belong to Asian nations and not more suitable data and 
proof supporting the ease of use Ganoderma lucidum in tumor 
patients. Whereas, Ganoderma lucidum utilized as alternate assistant 
to animate host immunity was established in a study involve 5 of 15 
gynecologic tumor patients attained constant disease later utilizing 
Ganoderma lucidum (fruiting body or spore) concentrate [27, 26].  
Safety Evaluation of Ganoderma supplementation described in 
double-blind placebo controlled cross over clinical trial relating the 
collected a month fasting blood or urine earlier or later 4 w of 
Ganoderma lucidum administered in healthy volunteers’ conclusions 
exhibit that there is no significant change in any of biochemical 
parameters or any sign of liver or renal toxicity seen in patients but 
lower lipid levels or antioxidant capacity in urine samples were 
increased in the end of trial [6]. 
Astudy carried out in 34 patients with advanced-stage malignancy 
observed impacts of Ganopoly on immune activity found that an 
increase immune feedback in progressive phase tumor patients by 
rise in quantity of CD3+cells. Another study found in enhanced 
mitogen-induced lympho-proliferative immune responses by 6 mo 
treatment of Ganoderma lucidum in children with tumor. While a 
trial study in 2012 proposed that Ganoderma lucidum spore powder 
delivered beneficial outcomes on cancer-associated fatigue or 
eminence of lifespan in 48 breast cancer patients receiving 
endocrine therapy with no unfavorable effect [49]. 
Additionally, Ganoderma lucidum produced positive effect in 
inhibited platelet aggregation in immunologically cooperated 
subjects and rises T lymphocyte or T helper cells, reductions in T 
suppressor cells, recovers immune capability afterwards chemo or 
radiation treatments. Moreover, hepatoprotective effect of 
Ganoderma lucidum (Reishi) stated by a minor uncontrolled study 
involving 4 hepatitis B patients or higher bilirubin or SGPT/SGOT 
levels remained receive 6 gm Reishi concentrate for 3 mo, following 
1-month time period investigate the bilirubin, SGPT or SGOT levels 
expressively decreased (**
A study employed in 134 patients by progressive tumors of various 
destinations or 12 w Ganoderma lucidum capsules treatment at dose 
1800 mg daily exhibit enhanced 80% the cellular immunity in 
relations of higher plasma IL-2, IL-6, interferon γ (IFN-γ) levels or 
natural killer (NK) cell movement. While similar procedure should 
be followed in 68 patients with lung cancer displayed increased 
immune constraints such as T cells, NK cells or CD4/CD8 proportion 
by treated group of Ganoderma lucidum with improving eminence of 
lifespan as far as “Karnofsky score” around 65% [7]. Another 
Polysaccharide property of Ganoderma lucidum infusion produced 
remedial impact on depression in adjuvant therapy of 
glucocorticoids as well as active in treating facial paralysis in 
children [28].  
P≤0.01) just as following 90 d all ideals 
got back to in typical extents [13]. 
Animal studies 
Rodent animal studies of Ganoderma lucidum with probable 
antitumorigenic effects should be carried out initial 1980s. In a trial 
for 10 d intraperitoneal (I. P) polysaccharide extract infusions (GL-
1) from fruit body of Ganoderma lucidum (Lingzhi or Reishi) observe 
to 95–98% inhibit transplanted sarcoma 180 tumor cells 
progression in mice. While, in study described a compound of 
polysaccharides and protein from mushroom display significant 
antitumor activity by reported 88% inhibition rate of whole relapse 
of tumor in third of test animals as well as similar procedure used in 
a study exhibit inhibition rate about 52–81%. Moreover, hot water 
extract receives I. P with 2 mg/mouse for 3 d lead a typical 74% 
restrain tumor development in mice by 3/10 animals display 
comprehensive deterioration or 45–63% inhibition in oral 
administration for 5 w daily. Another, dry powder formulation of 
Ganoderma lucidum (antlered form) produce effect in inhibited 
tumor development or lengthen life expectancy equally allogeneic 
sarcoma-180-bearing ddY mice or synergetic MM-46 mammary 
tumor–bearing C3H/He mice. A traditional herbal formulation i.e. 
TBS-101 proved to restrain tumor development or aggression in PC-
3-implanted mice. In a study found that oral administration of 
mycelial extract for 9 w showed lung adenoma development 
prevention in mice. While 18 d orally administered triterpenoid 
extract repressed Martigel-actuated angiogenesis by decreased 
tumor mass or quantity of tumor cell provinces in metastasized liver 
of C57BL/6J strain female mice by intra splenic embedding of Lewis 
lung cancer cells. whereas, male ICR-nu/nu nude mice infused 
hepatoma HepG2 cells, received 68 d orally lucidenic acid–rich 
concentrate with 800 mg/kg daily dose exhibit equally reduced 
amount or extent of cancers (99%) in liver or lung [7]. 
Another activity of GLPS by I. V 80 mg/kg injected to rats shown delay 
sleeping time or recover sleeping superiority. Various studies 
established, GLPS can build the degree of SOD or certain quantities of 
leucocytes. While in 3 autonomous studies examined the antibacterial 
activity of GLPS as well as another study detected the anti-skin ageing 
purpose of GLPS via rises mutually hydroxyproline or SOD substance 
in concentration-dependent manner. More studies exhibit GLPS is 
hepatoprotective in metabolic aberrations of diabetic mice, avoids or 
interruptions development of diabetic renal difficulties as well as GLPS 
helps blood circulation and eliminates blood stasis [28]. 
Ganoderma lucidum are also stimulating anti-androgenic activity 
with testosterone induced hyperplasia model in rats via week by 
week urine yield, testosterone levels or prostatic explicit antigen 
levels. The petroleum ether concentrate of Ganoderma lucidum is an 
effective inhibitor of prostatic hyperplasia incited via testosterone 
that confirmed in histological examinations on prostate segments 
and furthermore found a potent 5α-reductase inhibitor produced a 
symptomatic mechanism against benign prostatic hyperplasia [13]. 
Anticancer effect of Ganoderma lucidum have been demonstrated via 
one study involving polysaccharides remained regulated ICR/S1c 
mice by embedded Sarcoma 180 tumor cells produced a strong 
inhibitory activity against tumor cells lines. According to an in vitro 
study of immune-modulating property of hot water or ethanol 
concentrate of Ganoderma lucidum were examined in murine 
macrophage cultures resulted that the two concentrates improved 
formation of IL-6 or NO mixture in dose dependent manner and both 
I. P administration extracts displayed thriving ICR mice from lethal I. 
P contamination of Escherichia coliform or also substantial anti-
tumor action opposed to strong type Sarcoma 180 in mice. 
Moreover, the β-glucan fraction of Ganoderan (GDN) produced 
similar effect in improved 4-fold NO production and 19-fold TNF-α 
production associated to controls group in rats. Alternative, direct in 
vitro tumoricidal action were identified to two steroidal complexes 
such as Ganoderic aldehyde A or ergosta-7,22-diene-2β,3α,9α-triol 
extracted from Reishi fruiting bodies (Ganoderma lucidum) 
displayed a critical inhibitory effect against human hepatoma 
PLC/PRF/5 via ED50 2.54 or 1.17μg/ml and KB cells by ED50 1.25 
or 0.89 μg/ml. additionally, Ganoderic acids A or C display inhibit 
farnesyl protein transferase (FPT) in vitro by restrain reticular-
activating system (RAS) dependent cell alteration can signify 
probable beneficial approach for tumor development. Whereas, 
immune-modulating or antitumor impacts informed oral intake of 
Reishi displayed secure against many grades of Adriamycin incited 
cellular toxicity in rats resulted reductions in leukocytes, platelets or 
furthermore cloudy swelling or vacuolar deterioration in heart, liver 
or kidney cells. However, there is no data and evidence with respect 
to reishi signify that anticancer activity in humans. Thus, direct 
tumoricidal activity has just demonstrated in vitro or immunological 
system of antitumor activity [14].  
Therapeutic profile 
Pharmacokinetics 
Pharmacokinetic profile of Ganoderma lucidum and their bio 
constituent i.e. Ganoderic acid-C2, B, K or-H identified in rat plasma 
afterwards orally receive of concentrate utilizing high-performance 
liquid chromatography and Ganoderiol F detected after oral or 
intravenous administration utilizing Liquid chromatography and 
mass spectrometry. While, Ganoderic acid-A or-F are well absorbed 
orally in plasma and bio-transformed by reduction, oxidation, 
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deacetylation, desaturation, hydroxylation, sulfation, or 
glucuronidation. Another major constituent of Ganoderic acid-D or-B 
are further metabolized which is distinguished in rat kidney or 
stomach. In case of triterpenes it is rapidly absorbed in plasma 
within minutes and metabolized by phases I or II biotransformation 
in rats earlier excreted into bile and eliminated in more than 2 h. 
The polarity of Ganoderic acids is low polar in nature that changed 
into polar metabolites help to easily excreted. Whereas, Ganoderiol F 
metabolized into Ganodermadiol in anaerobic growth via bacterial 
culture and was detected in rat feces [26, 14].  
Pharmacodynamics 
The pharmacodynamics profile of Ganoderma lucidum are not clearly 
defined due to absence of specific database regarding with Ganoderma 
lucidum. However, Ganoderma lucidum (Reishi) are most widely 
researched remedial mushroom in Asia. Several pharmacological 
studies and scientific legislatures carried out to focused on chemistry 
and medical applications with specific therapeutic activity include 
immune enhancing, cardiovascular-regulating, hypoglycemic, and 
hepatoprotectant with polysaccharide and triterpene fractions and 
most of them conducted in China and Japan [14]. 
Dosage 
The effective dosage of Ganoderma lucidum for people has not 
entrenched but an analysis (1994b) stated Reishi mushroom recipe 
about 22-108 mg every day of crude herb in Ben Cao Gang Mu of Li 
Shi-Zhen. While, use of dose 0.05 mg/kg of β-glucan can produce in 
vivo white blood cell microbial killing action by acting β-glucan 
receptor on human WBC and based on relative effective dose 
concentration of Reishi mushroom estimated 300 mg and maximal 
effective dose is around 35 g daily. However, a research (1994) 
mentioned dosage range of 3-15g [14]. 
Additionally, the Ganoderma lucidum are present and mainly given 
in different formulae that may infused like powdered spore liquid 
formulation or might consumed like soup, syrup, tea, tablets, 
capsules, tincture and bolus. However, 20% dose in tincture formula 
taken 10 ml for 3 times daily, tablet 1g three times daily or syrup 4–
6 ml/day and if there should be an occurrence of ingestion of toxic 
mushrooms, dried 120–200g of Ganoderma lucidum is decocted in 
water or given as 3–5 times daily [16]. 
According to Pharmacopoeia of People’s Republic of China enclose 
newly added monograph in favor of Reishi referring with dose 6-12 
g everyday include as:  
Powder 
6-12 g daily.  
Decoction 
Around 375 ml two time every day. 
Tincture (1:5) 
10 ml for thrice every day. 
Rice wine extract 
30 ml for two times every day [14]. 
Side effects  
Clinicians have informed slight digestive distressed or skin rashes in 
sensitive persons and risk factor of cardiovascular disease (by 
inhibition HMG-CoA reductase and coenzyme Q10 deficiency) [14]. 
Another side effect develops by oral doses (1.5–9 g/day) of powder 
extract of Reishi reported lethargy, thirst, rashes, swelling, incessant 
urination, irregular sweating or bulky oral doses of vitamin C of 6–
12 g/day taken in combination with Reishi powder extract of 2–10 
g/day reported countered diarrhea. Furthermore, restraint of 
platelet accretion produced additive effect via Ganoderma lucidum 
with taking blood thinning medicines (aspirin or warfarin) [16].  
Contraindications 
Due to Immune-modulating activity of reishi mushroom should be 
keep away from organ transplanted patients using immune-
suppressive agents or autoimmune diseases caused patients. 
Moreover, Reishi mushroom extracts contain a complex mixture of 
allergens that should be withdrawn before surgery by reason of 
vasodilatory activity or platelet inhibitory activity. Moreover, 
consult the doctor/health professional for using of Reishi (due to 
hypoglycemic activity) for those patients using hypoglycemic 
medications and also consult the doctor for using of Reishi 
mushrooms (due to platelet aggregation-inhibitory activity) for 
those patient using anticoagulants [14].  
Interactions 
Reishi (Ganoderma lucidum) enhance the tranquillizing activity of 
reserpine or chlorpromazine as well as provoke central stimulating 
action of amphetamines. Alternative, Ganoderma lucidum (Reishi) 
enhance the action of lovastatin and other lipid lowering drugs as a 
result of its inhibitory activity on HMG-CoA and also shown to potentiate 
the antioxidant effects of glutathione. Moreover, Ganoderma lucidum 
reported immune-enhancing activity that should be contraindicated in 
combination of post organ transplant immunosuppressive agent and 
also be polysaccharides of Ganoderma lucidum antagonize 
immunosuppressive impacts of morphine in vitro or in vivo [14, 16]. 
Toxicity 
The several animal trials or toxicology studies displayed a very low 
toxicity with wide variety of fruiting body preparations. Whereas, a 
toxicology investigation of Reishi mushroom carried out in Hunan 
Medical College, China described 30 d Intragastric administration of 
Ganoderma lucidum ethanol concentrate (1.2 or 12 g/kg i. g. daily) 
displayed no impact or toxicity indications in rats on development 
or improvement or slightly aberrations in liver situation, ECG or 
detected in significant organs. Moreover, no harmful responses 
identified in 15 d dogs administered cold ethanol concentrate 12 
gm/kg i. g daily or 13 d administered hot ethanol concentrate 24 
gm/kg i. g every day display sleepiness. In a review (1994) reported 
30 d administered orally 5000 mg/kg hot water concentrate to mice 
resulted not any fluctuations seen in body or organ weight, 
hematological variables or polysaccharide segment equal dose 
formed no toxic or genuine impacts. Additionally, LD50 of I. P 
infusion of unclear Reishi formulation in mice informed as 
38.3±1.048 g/kg i. g and not any noxiousness establish 10 d 
receiving Reishi mushroom syrup as 2-4 ml/kg p. o. every day in 
dogs and 10 d intragastric administration of 4 ml/kg p. o. every day 
in rabbits [14]. Another activity of mushroom at dosage 10 gm/kg p. 
o. displayed not any variations of estrus cycles in ovariectomized 
mice or no rise in corpus cavernosa or testicles weight in male mice 
with equal dose. Another trial of toxicity of wild fruit bodies of 
Reishi analyzing intense toxicity by administered concentrate 
mixture (0.9259/kg) to male mice with equally one dose usually 
proposed with extract concentration resulted to cause acute toxicity, 
not any changes in uric acid, GOT and GPT as well as not any changes 
obtain in histological assessments of livers, kidneys, heart, lung, 
spleen and organ weights ratios compared to controls [16].  
Novel approaches of mushroom in treatment of cancer therapy 
Vaccinotherapy 
The novel approaches of vaccine preparations were newly 
established in Belgium and USA with preventive possessions against 
liver, cervical cancer, related with hepatitis B and human 
papillomatosis infections. Though, addition of immunomodulating 
constituents from natural and synthetic source to vaccines can 
necessarily improve their anticancer properties. However, at the 
same time up to date there is no vaccine on commercial scale were 
developed to cure present tumors, metastases or relapses. 
Consequently, an isolated Ganoderma lucidum (mycelia) 
immunomodulating Ling Zhi-8 protein has been attained in patented 
yeast system exhibit stimulatory activity on dendritic cells and also 
expressively increases the effectiveness of cancer DNA vaccine in a 
preclinical tumor model was newly recognized [57]. 
Nanotechnology  
The advancement of nanotechnology (nanoparticles) is an extremely 
focused new approaches using “green” chemistry and bioprocess 
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method involve in delivery and controls the release of drug in site of 
action to provide effective and less toxic treatment. These characteristic 
of living organisms play vital role for potential production of 
nanoparticles that involving the synthesis of unequal shaped gold 
nanoparticles with the help of photo-irradiation technique using 
reductant namely “Pleurotus florida”. The factor of flavins 
(flavoproteins) in mushroom extract cause decrease of ions into 
nanoparticles through contact to sunlight via absorb photons of energy 
or act in reduction-oxidation reactions. However, acquired nanoparticles 
presented cytotoxicity against A-549, K-562, HeLa, and MDA-MB cancer 
cells but no produced effect against Vero normal cells [57]. 
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